Skip to content
lifestyle.onebyfourstudio.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alzamend Neuro, Inc.
Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
September 16, 2026
Alzamend Neuro’s Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
August 20, 2026
Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending
August 4, 2026